Certified by Founder Lodge
Rock Springs Capital
United States - Baltimore, Maryland
INVESTOR
1 Disclosed Funding Rounds $135,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Rock Springs Capital is an investment firm that manages long-biased, healthcare-focused public equity funds.
| Company | Date | Round | Raised |
|---|---|---|---|
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
 Apollo Therapeutics |
September, 11 ,2023 | Series C | $226,500,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
